Open AccessEffect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study
Author(s) -
Bengt Fellström,
Hallvard Holdaas,
Alan G. Jardine,
Helen Rose,
Roland E. Schmieder,
Wim Wilpshaar,
Faı̈ez Zannad
Publication year - 2007
Publication title -
kidney and blood pressure research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.806
H-Index - 51
eISSN - 1423-0143
pISSN - 1420-4096
DOI - 10.1159/000106803
Subject(s) - medicine , rosuvastatin , population , kidney disease , placebo , hemodialysis , alternative medicine , environmental health , pathology
Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom